Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 32, 2020 - Issue 13-14
103
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Ultrafine urban particle measurements in Budapest and their airway deposition distribution calculation

, , , &
Pages 494-502 | Received 18 Feb 2020, Accepted 06 Nov 2020, Published online: 07 Dec 2020

References

  • Balasubramanian SK, Poh KW, Ong CN, Kreyling WG, Ong WY, Yu LE. 2013. The effect of primary particle size on biodistribution of inhaled gold nano-agglomerates. Biomaterials. 34(22):5439–5452.
  • Broday DM. 2004. Deposition of ultrafine particles at carinal ridges of the upper bronchial airways. Aerosol Sci Tech. 38(10):991–1000.
  • Calderón-Garcidueñas L, Engle R, Antonieta Mora-Tiscareño AM, Styner M, Gómez-Garza G, Zhu H, Jewels V, Torres-Jardón R, Romero L, Monroy-Acosta M, et al. 2011. Exposure to severe urban air pollution influences cognitive outcomes, brain volume and systemic inflammation in clinically healthy children. Brain Cogn. 77(3):345–355.
  • Campbell A, Oldham M, Becaria A, Bondy SC, Meacher D, Sioutas C, Misra C, Mendez LB, Kleinman M. 2005. Particulate matter in polluted air may increase biomarkers of inflammation in mouse brain. Neurotoxicology. 26(1):133–140.
  • Chan K, Schneider A, Cyrys J, Wolf K, Meisinger C, Heier M, von Scheidt W, Kuch B, Pitz M, Peters A, et al. 2020. Hourly exposure to ultrafine particle metrics and the onset of myocardial infarction in Augsburg, Germany. Environ Health Perspect. 128:017003.
  • Cohen AJ, Brauer M, Burnett R, Anderson HR, Frostad J, Estep K, Balakrishnan K, Brunekreef B, Dandona L, Dandona R, et al. 2017. Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015. Lancet. 389(10082):1907–1918.
  • Daigle CC, Chalupa DC, Gibb FR, Morrow PE, Oberdörster G, Utell MJ, Frampton MW. 2008. Ultrafine particle deposition in humans during rest and exercise. Inhal Toxicol. 15(6):539–552.
  • EEA Report. 2019. No 21/ Healthy environment, healthy lives: how the environment influences health and well-being in Europe. ISSN 1977–8449.
  • Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, Potter R, Maynard A, Ito Y, Finkelstein J, et al. 2006. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Persp. 114(8):1172–1178.
  • Ferin J. 1994. Pulmonary retention and clearance of particles. Toxicol Lett. 72(1–3):121–125.
  • Fonken LK, Xu X, Weil ZM, Chen G, Sun Q, Rajagopalan S, Nelson RJ. 2011. Air pollution impairs cognition, provokes depressive-like behaviors and alters hippocampal cytokine expression and morphology. Mol Psychiatry. 16(10):987–995.
  • Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, Burnett R, Casey D, Coates MM, Cohen A, et al. 2015. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 386(10010):2287–2323.
  • Ge QJ, Inthavong K, Tu JY. 2012. Local deposition fractions of ultrafine particles in a human nasal-sinus cavity CFD model. Inhal Toxicol. 24(8):492–505.
  • Geiser M, Kreyling WG. 2010. Deposition and biokinetics of inhaled nanoparticles. Part Fibre Toxicol. 7:2.
  • Geiser M, Rothen-Rutishauser B, Kapp N, Schürch S, Kreyling W, Schulz H, Semmler M, Hof VI, Heyder J, Gehr P. 2005. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect. 113(11):1555–1560.
  • [HEI] Health Effects Institute. 2013. Understanding the health effects of ambient ultrafine particles. HEI perspectives 3. Boston (MA): Health Effects Institute.
  • Heyder J, Gebhart J, Rudolf G, Schiller CF, Stahlhofen W. 1986. Deposition of particles in the human respiratory tract in the size range 0.005 to 15 µm. J Aerosol Sci. 17(5):811–825.
  • Hofmann W. 2011. Modelling inhaled particle deposition in the human lung- a review. J Aerosol Sci. 42(10):693–724.
  • Hofmann W, Koblinger L. 1990. Monte Carlo modeling of aerosol deposition in human lungs. Part II: deposition fractions and their sensitivity to parameter variations. J Aerosol Sci. 21(5):675–688.
  • Hofmann W, Koblinger L. 1992. Monte Carlo modeling of aerosol deposition in human lungs. Part III: comparison with experimental data. J Aerosol Sci. 23(1):1, 51–63.
  • Ibald-Mulli A, Wichmann HE, Kreyling W, Peters A. 2002. Epidemiological evidence on health effects of ultrafine particles. J Aerosol Med. 15(2):189–201.
  • [ICRP] International Commission on Radiological Protection. 1994. Human respiratory tract model for radiological protection. ICRP Publication 66. Ann ICRP. 24:1–3.
  • Jaques PA, Kim CS. 2000. Measurement of total lung deposition of inhaled ultrafine particles in healthy men and woman. Inhal Toxicol. 12:715–731.
  • Kawanaka Y, Tsuchiya Y, Yun SJ, Sakamoto K. 2009. Size distributions of polycyclic aromatic hydrocarbons in the atmosphere and estimation of the contribution of ultrafine particles to their lung deposition. Environ Sci Technol. 43(17):6851–6856.
  • Koblinger L, Hofmann W. 1990. Monte-Carlo modeling of aerosol deposition in human lungs. Part I. Simulation of particle-transport in a stochastic lung structure. J Aerosol Sci. 21(5):661–674.
  • Kreyling WG, Scheuch G. 2000. Clearance of particles deposited in the lungs. In: Heyder J, Gehr P, editors. Particle lung interactions. New York (NY): Marcel Dekker; p. 323–376.
  • Kreyling WG, Semmler MB, Takenaka S, Möller W. 2013. Differences in the biokinetics of Inhaled nano-versus micrometer-sized particles. Acc Chem Res. 46(3):714–722.
  • Möller W, Felten K, Sommerer K, Scheuch G, Meyer G, Meyer P, Häussinger K, Kreyling WG. 2008. Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. Am J Respir Crit Care Med. 177(4):426–432.
  • Oberdörster G, Ferin J, Gelein R, Soderholm SC, Finkelstein J. 1992. Role of the alveolar macrophage during lung injury: studies with ultra-fine particles. Environ Health Perspect. 97:193–199.
  • Oberdörster G, Gelein RM, Ferin J, Weis B. 1995. Association of particulate air pollution and acute mortality: Involvement of ultra-fine particles? Inhal Toxicol. 7(1):111–124.
  • Raabe OG, Yeh HC, Schum GM, Phalen RF. 1976. Tracheobronchial geometry: human, dog, rat, hamster, Lovelace foundation report LF-53. Albuquerque (NM): Lovelace Foundation.
  • Salma I, Füri P, Németh Z, Balásházy I, Hofmann W, Farkas Á. 2015. Lung burden and deposition distribution of inhaled atmospheric urban ultrafine particles as the first step in their health risk assessment. Atmos Environ. 104:39–49.
  • Seaton AW, Godden D, MacNee W, Donaldson K. 1995. Particulate air pollution and acute health effects. Lancet. 345(8943):176–178.
  • Thurston GD, Kipen H, Annesi-Maesano I, Balmes J, Brook RD, Cromar K, Matteis SD, Forastiere F, Forsberg B, Frampton MW, et al. 2017. A joint ERS/ATS policy statement: what constitutes an adverse health effect of air pollution? An analytical framework. Eur Respir J. 49(1):1600419.
  • Valavanidis A, Fiotakis K, Vlachogianni T. 2008. Airborne particulate matter and human health. Toxicological assessment and importance of size and composition of particles for oxidative damage and carcinogenic mechanisms. J Env Sci Health. 26:339–362.
  • Yang J, Kim JK, Kang TS, Jee YK, Kim YY. 2017. Importance of indoor dust biological ultrafine particles in the pathogenesis of chronic inflammatory lung diseases. Environ Health Toxicol. 32:e2017021.
  • Yu CP, Diu CK, Soong TT. 1981. Statistical analysis of aerosol deposition in nose and mouth. Am Ind Hyg Assoc J. 42(10):726–733.
  • Zhang Z, Kleinstreuer C, Kim CS. 2008. Airflow and nanoparticle deposition in a 16-generation tracheobronchial airway model. Ann Biomed Eng. 36(12):2095–2110.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.